Orchid Pharma Ltd
BSE: 524372
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 304.17+28.0% | 237.61+14.6% | 207.27+7.1% | 193.52+11.9% | 172.93-27.2% | 237.48+9.3% | 217.34-2.4% | 222.70 |
| Other Income | 10.05-24.4% | 13.30+25.6% | 10.59-31.3% | 15.43-3.2% | 15.93+154.6% | 6.26-37.0% | 9.94+24.8% | 7.96 |
| Total Income | 314.22+25.2% | 250.90+15.2% | 217.86+4.3% | 208.95+10.6% | 188.86-22.5% | 243.74+7.2% | 227.28-1.5% | 230.66 |
| EXPENSES | ||||||||
| Expenditure | 302.28+36.9% | 220.84+2.0% | 216.57+4.8% | 206.72+21.1% | 170.66-20.9% | 215.89+6.2% | 203.37-0.8% | 205.04 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | 11.94-61.0% | 30.60+625.4% | -5.82-361.1% | 2.23-87.7% | 18.20-34.7% | 27.85+16.5% | 23.91-6.7% | 25.63 |
| Net Profit | 11.94-61.0% | 30.60+625.4% | -5.82-361.1% | 2.23-87.7% | 18.20-34.7% | 27.85+16.5% | 23.91-6.7% | 25.63 |
| KEY METRICS | ||||||||
| OPM % | 4.93%-7.50pp | 12.43%+14.49pp | -2.06%-1.71pp | -0.35%-8.55pp | 8.20%-6.26pp | 14.46%+13.74pp | 0.72%-1.86pp | 2.58% |
| NPM % | 3.80%-8.40pp | 12.20%+14.87pp | -2.67%-3.74pp | 1.07%-8.57pp | 9.64%-1.79pp | 11.43%+0.91pp | 10.52%-0.59pp | 11.11% |
| EPS | 1.99-67.0% | 6.03+424.3% | 1.15+161.4% | 0.44-87.7% | 3.59-34.6% | 5.49+16.6% | 4.71-6.7% | 5.05 |
Corporate Events
Board MeetingORCHPHARMA
202614Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingORCHPHARMA
20261Aug
Board Meeting
The meeting of the Board of Directors of Orchid Pharma Limit…
BSE Filing ↗ Board MeetingORCHPHARMA
202610Jul
Board Meeting
The Board of Directors considered, noted and approved the ef…
BSE Filing ↗ Board MeetingORCHPHARMA
202625May
Board Meeting
The board meeting is scheduled to consider and approve Audit…
BSE Filing ↗ Board MeetingORCHPHARMA
202412Aug
Board Meeting
consider and approve Unaudited Limited Reviewed Financial Re…
BSE Filing ↗ Board MeetingORCHPHARMA
202423May
Board Meeting
Consider and approve Audited Standalone & Consolidated Finan…
BSE Filing ↗ Board MeetingORCHPHARMA
20248Feb
Board Meeting
Consider and approve Un-Audited Standalone & Consolidated Fi…
BSE Filing ↗ Board MeetingORCHPHARMA
20234Nov
Board Meeting
Approval of Unaudited Standalone and Consolidated Financial …
BSE Filing ↗ Board MeetingORCHPHARMA
202310Aug
Board Meeting
Consider and approve Un-Audited Financial Result (Standalone…
BSE Filing ↗